Editorial: Targeting mitochondrial dysfunction for the diagnosis and treatment of Alzheimer’s and cognitive-related diseases

• Manos C. Vlasiou,
• Lefteris C. Zacharia,
• Lefteris C. Zacharia,
• Eleni Douni,
• Eleni Douni,
• Christos Papaneophytou,
• Christos Papaneophytou

Affiliations

Manos C. Vlasiou

School of Veterinary Medicine, University of Nicosia, Nicosia, Cyprus

Lefteris C. Zacharia

Department of Health Sciences, School of Life and Health Sciences, University of Nicosia, Nicosia, Cyprus

Lefteris C. Zacharia

Bioactive Molecules Research Center, School of Life and Health Sciences, University of Nicosia, Nicosia, Cyprus

Eleni Douni

Institute for Bioinnovation, Biomedical Sciences Research Center “Alexander Fleming”, Vari, Greece

Eleni Douni

Laboratory of Genetics, Department of Biotechnology, Agricultural University of Athens, Athens, Greece

Christos Papaneophytou

Bioactive Molecules Research Center, School of Life and Health Sciences, University of Nicosia, Nicosia, Cyprus

Christos Papaneophytou

Department of Life Sciences, School of Life and Health Sciences, University of Nicosia, Nicosia, Cyprus